North Growth Management Ltd. Has $12.88 Million Stock Holdings in Integer Holdings Co. (NYSE:ITGR)

North Growth Management Ltd. lowered its stake in Integer Holdings Co. (NYSE:ITGR) by 2.0% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 97,000 shares of the medical equipment provider’s stock after selling 2,000 shares during the period. Integer makes up 2.5% of North Growth Management Ltd.’s investment portfolio, making the stock its 14th biggest position. North Growth Management Ltd.’s holdings in Integer were worth $12,876,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of ITGR. Eagle Asset Management Inc. bought a new position in shares of Integer during the third quarter valued at $14,403,000. Laurus Investment Counsel Inc. bought a new position in Integer during the 4th quarter worth $5,422,000. Bamco Inc. NY lifted its holdings in Integer by 17.4% during the 3rd quarter. Bamco Inc. NY now owns 254,377 shares of the medical equipment provider’s stock worth $33,069,000 after buying an additional 37,700 shares during the period. Jane Street Group LLC grew its position in shares of Integer by 23.3% in the 3rd quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider’s stock valued at $19,682,000 after buying an additional 28,572 shares during the last quarter. Finally, Point72 DIFC Ltd bought a new stake in shares of Integer in the 3rd quarter valued at about $2,977,000. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Stock Performance

Shares of ITGR opened at $140.37 on Friday. The firm has a market capitalization of $4.71 billion, a P/E ratio of 43.32, a P/E/G ratio of 1.79 and a beta of 1.13. Integer Holdings Co. has a 52 week low of $94.56 and a 52 week high of $146.36. The stock has a 50 day moving average price of $137.94 and a two-hundred day moving average price of $131.02. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28.

Analysts Set New Price Targets

A number of research firms recently commented on ITGR. KeyCorp lifted their price objective on Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Piper Sandler restated an “overweight” rating and set a $140.00 target price (up previously from $125.00) on shares of Integer in a research report on Friday, October 25th. Wells Fargo & Company reissued an “overweight” rating and issued a $160.00 price target on shares of Integer in a research note on Tuesday, December 3rd. Benchmark lifted their price objective on shares of Integer from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, October 21st. Finally, Citigroup increased their target price on shares of Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a research note on Wednesday, December 11th. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $146.56.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.